Anti-Human CD23 Therapeutic Antibody (Gomiliximab)
Recombinant monoclonal antibody to CD23. Gomiliximab is a monoclonal antibody acting as an immunosuppressive drug for the treatment of allergic asthma. It targets the low affinity IgE receptor (FcεRII or CD23). The drug is a chimeric antibody from Macaca irus and Homo sapiens.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-231 |
| Pricing | Inquiry |
| Host | primate |
| Target | CD23 |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | Suitable for use in WB, Neut, ELISA, IF, IP, FuncS, FC and most other immunological methods. |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |